Saccharomyces cerevisiae fungaemia associated to multiple foci pneumonia in a patient affected by alcohol-related hepatic cirrhosis;Fungemia da Saccharomyces cerevisiae con polmonite a focolai multipli in paziente con cirrosi epatica alcool correlata

Infezioni in Medicina

Volumn 16, Issue 4, 2008, Pages 227-229

  Montineri, Arturo ^a   Iacobello, Carmelo ^a   Larocca, Licia ^a   La Rosa, Rosario ^a   Nigro, Luciano ^b   Fatuzzo, Filippo ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Liposomal amphotericin B; Saccharomyces cerevisiae; Sepsis

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; PROBIOTIC AGENT; VORICONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; FUNGEMIA; HUMAN; IMMUNOCOMPROMISED PATIENT; LIVER CIRRHOSIS; PNEUMONIA; SACCHAROMYCES CEREVISIAE; YEAST;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; DRUG THERAPY, COMBINATION; FLUCONAZOLE; HUMANS; IMMUNOCOMPROMISED HOST; ITRACONAZOLE; LIVER CIRRHOSIS, ALCOHOLIC; LUNG DISEASES, FUNGAL; MALE; MIDDLE AGED; PYRIMIDINES; SACCHAROMYCES CEREVISIAE; TREATMENT OUTCOME; TRIAZOLES;

EID: 59349090344     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Munoz P., Bouza E., Cuenca-Estrella M., et al. Saccharomyces cerevisiae Fungemia: An Emerging Infectious Disease. Clin. Infect. Dis. 4, 1625-1634, 2005.
2. Bassetti S., Frei R., Zimmerli W. Fungemia with Saccharomyces cerevisiae after treatment wih Sacharomyces boulardi. Am. J. Med. 105, 71-72, 1998.
3. Tawifik O., Papasian C., Dixon A. et al. Saccharomyces Cerevisiae Pneumonia in a Patient with Acquired Immune deficiency Syndrome. J. Clin. Microbiol. 27, 1689-1691, 1989.
4. Candelli M., Nista E.C., Nestola M., Armuzzi A., Silveri N.G., Gasbarrini G., Gasbarrini A. Sacharomyces cerevisiae-associated diarrhea in an immunocompetent patient with ulcerative colitis. J. Clin. Gastroenterol. 36, 39-40, 2003.
5. Ghassemi S., Garcia-Tsao G. Prevention treatment of infections in patients with cirrhosis. Best Pract. Res. Clin. Gatsroenterol. 21, 77-93, 2000.
6. Rosa H., Silvério A.O., Perini R.F., Arruda C.B. Bacterial infection in cirrhotic patients and its relationship with alcohol. Am. J. Gastroenterol. 95, 1290-1293, 2000.
7. Marvaso A. Central venous catheter-related infections. Infez. Med. 8, 202-210, 2000.
8. Gales G., Penninchx M., Block J.C., Leroy P. Role of Glutathione metabolism status in the definition of some cellular parameters and oxidative stress tolerance of Saccharomyces cells growing as biofilms. FEMS Yeast Res. 16, 2008, Published Online: DOI: 10.1111/j.1567-1364.2008.00401.x.
9. Kuhn D.M., George T., Chandra J., Mukherjee P.K., Ghannoum M.A. Antifungal Susceptibility of Candida Biofilms: Unique Efficacy of Amphotericin B Lipid Formulations and Echinocandins. Antimicrob. Agents Chemother. 46, 1773-1780, 2002.
10. Douglas L.J. Medical impoirtance of biofilms in Candida infections. Rev. Iberoam. Micol. 19, 139-143, 2002.
11. Rodriguez D., Park B.J., Almirante B., Cuenca-Estrella M., et al. Barcellon Candidemia Project Study Group. Impact of early central venous catheter removal on outcome in patients with candidemia. Clin. Microbiol. Infect. 13, 516-517, 2007.
12. Pasqualotto AC, Severo LC. The importance of central venous catheter removalin patients with candidemia: time to rethink our practice? Clin. Microbiol. Infect. 14, 2-4, 2008.